Introduction

Knee osteoarthritis is a common and often painful condition that can make everyday movement difficult. As more people look for ways to ease their symptoms without surgery, injection treatments have gained popularity as effective options for pain relief and better joint function.

Among the available injections, Arthrosamid, steroid (corticosteroid), and hyaluronic acid each work differently and offer various benefits. Understanding these differences can be confusing but is essential when exploring treatment choices.

Patient-centred care encourages people to learn about their options before making decisions. This article explains how each injection works, their advantages and drawbacks, and practical tips to help you talk confidently with your healthcare provider.

How Each Injection Works: What Happens Inside the Knee?

Injection treatments work by delivering medicine directly into the knee joint to reduce pain and improve movement. But each type works in its own way.

Arthrosamid is a gel-like substance that cushions the joint. It “adheres to and bulks up the synovial membrane and acts as a scaffold to treat the synovium,” according to recent studies. In simple terms, it forms a protective layer inside the knee, helping reduce friction and provide longer-lasting support.

Steroid injections tackle inflammation, which is often the source of pain and swelling. They work quickly to calm the joint but don’t repair the damaged cartilage underneath.

Hyaluronic acid injections top up the joint’s natural fluid, which lubricates and cushions the knee. They help movement feel smoother and reduce discomfort but don’t have the immediate anti-inflammatory effects of steroids.

How Long Can You Expect Relief to Last?

The duration of relief from injections varies based on the type and individual patient factors.

Arthrosamid has shown promising results for lasting relief—effective for up to a year or more. Research found “statistically significant data… at both 52 weeks and 13 months,” with benefits even continuing “at 2 years” in some cases.

Another study showed that Arthrosamid (also known as iPAAG) “outperformed steroid injections at 6 months,” though its advantages over hyaluronic acid were less clear. At 12 months, differences between treatments tend to level out, indicating that while Arthrosamid offers some extended benefit, no injection is a permanent fix.

Steroid injections generally provide quicker but shorter-lasting relief—often a few weeks to months. They’re useful if you need fast symptom control but should not be used too frequently due to potential risks.

Hyaluronic acid injections typically help for around six months. Many patients receive several injections over time for the best effect.

It's important to have realistic expectations—these injections help manage symptoms, but their effects can vary from person to person.

Safety and Suitability: What You Should Know

Safety is a key consideration with any treatment.

Arthrosamid injections are generally safe, with few long-term side effects reported. One review states that “injection of PAAG hydrogel… has been shown to be safe with no long-lasting adverse events.” Laboratory studies also confirm that these hydrogels show “no neurotoxic or cytotoxic effects,” meaning they do not harm nerve or other cells.

Steroid injections carry some risks, including possible infection, skin thinning, and flare-ups after treatment. People with conditions like diabetes should take special care. Frequent steroid use is not recommended due to the possibility of harming the joint cartilage.

Hyaluronic acid injections are typically well tolerated. Side effects are usually mild, such as temporary pain or swelling.

Always discuss any health conditions or concerns with your doctor before starting injection treatments.

Practical Advice: Choosing the Best Injection for You

Choosing the right injection depends on your goals, health, and lifestyle.

A recent study summed it up well: “iPAAG offers comparable short-term efficacy and modest advantage at 6 months. However, long-term superiority is limited.” This means Arthrosamid can be a useful option, especially if you want longer-lasting relief than steroids typically offer.

Ask your doctor:

• How might each injection benefit my specific condition?
• What side effects should I watch for?
• Will I need repeat injections?
• How will these fit with my overall treatment plan?

Patient-centred care recognises that one treatment doesn’t fit all.

Expert Care and Support from MSK Doctors and Professor Paul Lee

Professor Paul Lee, a respected cartilage expert, brings extensive knowledge to help patients navigate complex options for osteoarthritis.

At MSK Doctors, patients receive expert, compassionate support to make choices that suit their individual needs. The clinic offers advanced treatment options, but always tailors care to achieve the best possible outcomes.

MSK Doctors also advocate for evidence-based practice, ensuring high standards and patient safety.

Conclusion

Understanding how Arthrosamid, steroid, and hyaluronic acid injections work helps you be confident in managing knee osteoarthritis. Each option has unique strengths, durations of relief, and safety considerations.

Talk openly with your healthcare professional to find the best injection option for your situation. Remember, expert advice and individualised care remain the cornerstones of effective osteoarthritis management.

Together, this approach can help you regain mobility and improve your quality of life.

References

• Cole, A., Maulana, R., Whitehead, J., & Lee, P. (2022). A systematic review of the novel compound Arthrosamid Polyacrylamide (PAAG) Hydrogel for treatment of knee osteoarthritis. MRA, 10(8). https://doi.org/10.18103/mra.v10i8.2950
• Aykaç, B., Dinç, M., Nar, Ö. O., Karasu, R., & Bayrak, H. Ç. (2025). Comparative efficacy of polyacrylamide hydrogel versus hyaluronic acid and corticosteroids in knee osteoarthritis: A retrospective cohort study. Medicine, 104(15). https://doi.org/10.1097/MD.0000000000044655
• Walmod, P. S., Kusk, P., Jøhnk, N., Ankorina-Stark, I., & Essex, A. (2025). An injectable 2.5% cross-linked polyacrylamide hydrogel (2.5 iPAAG) demonstrates no neurotoxicity in human induced pluripotent stem cells-derived iCell® GlutaNeurons. Frontiers in Toxicology. https://doi.org/10.3389/ftox.2025.1585430